The GTS Institute

BIONEER

Hjem / English / The GTS Institutes / Bioneer english

Transforming scientific advancements into better Life Science solutions for tomorrow, Bioneer is a trusted strategic R&D partner to biotech and pharmaceutical companies, founded in 1982.

We are a Danish innovative specialty CRO, creating customized research service solutions that meet the needs of our customers.

We help them develop and produce their promising early drug candidates from as early on as their inception, and we generate key early insights into their mechanisms, efficacy and safety.

As extended R&D team and trusted strategic partner, we bring value with our unique know-how and advanced technologies.

With a staff of dedicated and highly skilled employees, state-of-the-art facilities in our two sites in the Copenhagen area, and a history of nearly 40 years of operation, Bioneer is fit to fulfil its dual role as a commercial entity with a societal obligation.

Core competencies


Cancer modelling

We create cancer in vitro systems to evaluate chemotherapeutics and immuno-oncology drug candidates.
We can assist in both simple or complex studies with few or several parameters, one or more cancer drug candidates of interest, in a multicellular milieu. We can test candidates alone or in combination with relevant commercially-available reference drugs.

Immunology

We provide a broad range of services, support and custom-made assays within immunology, at all levels from basic research and early discovery to clinical sample evaluation. We understand the importance of ensuring quality, safety and efficacy of biopharmaceuticals in development from an immunological perspective.

CNS modelling

We develop CNS models based on iPS cell lines and immortalized cell lines. Our team use gene editing, neural differentiation technologies and image based screening to develop models that mimic a specific CNS disease.
We understand the complexity of CNS in vitro modelling, and we can custom design or tailor CNS models to fit your purpose.

Gastro-intestinal modelling

We are specialized in oral drug delivery and have developed a range of in vitro models simulating the behaviour of drugs and drug products in the gastro-intestinal tract.
We use a broad selection of cell culture models to assess drug permeability and absorption mechanism.

Recombinant proteins

We help our clients get from their idea to their first protein and product. We are experts in all aspects of expression, purification, characterization, formulation and small-scale manufacturing of recombinant protein.

Peptides

We develop pre-formulation strategies, and we design and perform the critical experiments necessary for creating stable peptides formulated according to regulatory requirements. We collaborate with private partners having a proven track record in bringing biologics through the pre-clinical and clinical phases to assist companies all the way.

Small molecules

We specialize in pre-formulation and strategic formulation of small molecules.

Specialized services

We are experts in all aspects of gene editing and in using it to establish custom cell lines. We offer a wide range of services in the field of molecular histology and detection. Also, we have extensive experience in helping companies turn active compounds into viable drug products.

Building new knowledge

Bioneer’s research strategy addresses novel solutions for drug discovery and development that fulfil future needs of companies, research institutes, and Health Care.

To be successful in developing a drug candidate, mode of action patterns needs to be resolved, therapeutic modalities needs to be tailored to provide optimal treatment and therapeutic outcomes have to be monitored.

We strive to develop “best in class” solutions and are currently running two ambitious R&D programs within:

  • In Vitro Models Assay & Development
  • Drug Candidate Development & Formulation

 

Testing, demonstration, and development facilities

Bioneer is located in the heart of Medicon Valley.  We have two sites in Denmark serving our partners globally.

Our main site and headquarters is located in Hørsholm, 20 minutes north of Copenhagen, in the heart of the Scion-DTU Science Park. This 3350m2 site is equipped with both offices and state-of-the-art lab facilities. Overall the site has 1400m2 office space, 450m2 of warehouse and 1500m2 of laboratory space.

We have a second site located at the Department of Pharmacy at the University of Copenhagen, Bioneer:FARMA.

This 180m2 site has offices and laboratories, it was established in 2007 in collaboration with the University of Copenhagen.

Revenue,mill. EUR.

21

R&D activities,mill. EUR.

2,9

Performance contract,mill. EUR.

1,9

Number ofemployees

65

Ownership, Management and Board of Directors


Ownership
  • Bioneer A/S is a not-for-profit organization and a subsidiary of the Technical University of Denmark (DTU).
Leadership
  • CEO - Lars Hagsholm Pedersen
Chairman of the Board of Directors
  • Kirsten Drejer
Board Members
  • Marianne Thellersen
  • Michael Pålsson
  • Søren Carlsen
  • Trine Winterø
  • Bjarke Bak Christensen
  • Bjørn Holst
  • Trine Møller
  • Søren Madsen

Bioneer A/S

Kogle Alle 2
DK-2970 Hørsholm

Tlf: (+45) 46 16 04 44
Mail: bioneer@bioneer.dk
Web: bioneer.dk